en · de · es · fr · pt
tirzepatide-notes.peptides6608.com › News › Dual Incretin Receptor Pharmacology — Deep Dive

Dual Incretin Receptor Pharmacology — Deep Dive

By Editorial Desk · published 2026-07-16 · last reviewed 2026-08-01 · News

Everything below concerns 合成肽. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.

Dual Incretin Receptor Pharmacology

Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.

At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.

Tirzepatide 分子背景与靶点

脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强,从而延长循环半衰期,支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征,减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用,属于既定的药代动力学策略。

该化合物的名称与结构由国际非专利名称体系统一维持,不同文献中出现的同义写法主要在拼写顺序或盐形式描述上不同。研究者通常通过受体结合实验、细胞内环磷酸腺苷积累测定以及动物模型来确认其双激动活性。相当一部分分子层面的细节——例如两条受体通路之间的信号交叉作用——尚处于开放问题状态。

Tirzepatide at a glance

PropertyValueNotes
Molecular formulaC225H348N48O6839-residue synthetic peptide
Average molecular massAbout 4813.5 DaFree base form
AppearanceWhite to off-white powderSolid after lyophilization
Solubility classFreely soluble in waterAlso soluble in neutral aqueous buffers
Typical storageAt or below -20 °C, desiccatedProtect from light and moisture

Background and Molecular Development

Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.

The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.

Related pages on this site

Background and Dual Receptor Pharmacology

Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.

Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.

Background from the literature

=== Nitrite test === The nitrite test is commonly used to diagnose urinary tract infections by measuring the concentrations of nitrite in solution, indicating the presence of a gram-negative organism. A simple nitrite test can be performed by adding 4 M sulfuric acid to the sample until acidic, and then adding 0.1 M iron (II) sulfate to the solution. A positive test for nitrite is indicated by a dark brown solution, arising from the iron-nitric oxide complex ion.

Low dietary vitamin B6 correlated with a higher risk of depression in women but not in men. When treatment trials were reviewed, no meaningful treatment effect for depression was reported, but a subset of trials in pre-menopausal women suggested a benefit, with a recommendation that more research was needed. The results of several trials with children diagnosed as having autism spectrum disorder (ASD) treated with high dose vitamin B6 and magnesium did not result in treatment effect on the severity of symptoms of ASD.

=== 2016 === The "UHD Alliance", an industry consortium of content creators, distributors, and hardware manufacturers, announced Monday on January 11, 2016 during CES 2016 press conference its "Ultra HD Premium" specification, which defines resolution, bit depth, color gamut, high dynamic range (HDR) performance required for Ultra HD (UHDTV) content and displays to carry their Ultra HD Premium logo. On April 2, 2016, Ultra-high-definition television demo channel UHD1 broadcast the Le Corsaire ballet in Ultra HD live from the Vienna State Opera. The programme was produced by Astra satellite owner, SES in collaboration with European culture channel ARTE, and transmitted free-to-air, available to anyone with reception of the Astra 19.2°E satellites and an ultra HD screen equipped with an HEVC decoder. As of April 2016, The NPD Group reported that 6 million 4K UHD televisions had been sold. In May 2016, Modern Times Group, owner of the Viasat DTH platform announced the launch of Viasat Ultra HD, the first UHD channel for the Nordic region. The channel features selected live sport events especially produced in Ultra HD and launch in the autumn via the SES-5 satellite at 5°E. Viasat is also launching an Ultra HD set-top box from Samsung and a TV-module that enables existing UHD TVs to display the channel. Satellite operator, SES said that the launch of Viasat Ultra HD brings the number of UHD channels (including test channels and regional versions) carried on SES satellites to 24, or 46% of all UHD channels broadcast via satellite worldwide.

Sources: en.wikipedia.org

Further detail

== Diagnosis == The diagnosis of MADD needs to be considered in patients who have exercise induced myalgia, cramps and sometimes weakness. A mildly elevated creatine kinase may also occur. Exclusion of other muscular diseases such as McArdle's Disease and carnitine cycle abnormalities should occur. MADD may be identified if there is a lack of ammonia rise after forearm exercise testing. The diagnosis may then be confirmed with genetic testing.

On the same day, Taliban officials released a video that they said showed Taliban forces demolishing a Pakistani military post in Kunar province, which they claimed to have captured earlier. Pakistani officials denied Taliban claims and said that military post lacks identifiable features of a Pakistani installation, such as the national flag or proximity to the international border fence. They further asserted that the demolished structure was an Afghan facility located within Afghan territory, not a Pakistani military post. On 28 March, tribal elders and residents of Nuristan urged Taliban authorities to reopen roads that had been closed for weeks, which residents attributed to Pakistani artillery shelling. Taliban officials pledged to address the issue, but said the closures were caused by natural factors. Residents described the situation in the Kamdesh and Bargi Matal districts as siege-like and warned that, if it continued for another week or two, it could lead to a humanitarian emergency and increase the risk of the districts falling to Pakistani forces. The closure of communication routes in districts of Nuristan, together with continued Pakistani artillery attacks in parts of Kunar and Nuristan, raised concerns among observers. Some suggested that the moves may have been intended to open a route or connection line for Taliban opponents in northern Afghanistan.

The clitoris develops from a phallic outgrowth in the embryo called the genital tubercle. In the absence of testosterone, the genital tubercle allows for the formation of the clitoris; the initially rapid growth of the phallus gradually slows and the body and glans of the clitoris are formed along with its other structures.

Sources: en.wikipedia.org

Frequently asked questions

What class of compound is tirzepatide?

It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.

How does the fatty acid chain affect the molecule?

The C20 fatty diacid promotes tight binding to serum albumin. That binding reduces renal clearance and extends circulation time compared with an unmodified peptide of similar length.

Is the role of each receptor fully established?

It is not fully established. Studies indicate that both receptors contribute to the observed effects, but the exact split between the two signaling pathways in humans remains an open question.

Tirzepatide 属于哪一类分子?

它属于合成修饰肽,同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂,与选择性 GLP-1 激动剂在靶点范围上不同。

Network